Calidi Biotherapeutics (CLDI) Earnings Date, Estimates & Call Transcripts $0.59 -0.01 (-0.92%) Closing price 08/1/2025 04:00 PM EasternExtended Trading$0.56 -0.03 (-4.62%) As of 08/1/2025 07:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Calidi Biotherapeutics Earnings Summary Calidi Biotherapeutics announced Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.65, which beat the consensus estimate of -$0.85 by $0.20. With a trailing EPS of $0.00, Calidi Biotherapeutics' earnings are expected to grow next year, from ($4.48) to ($0.88) per share. Nov. 12 Earnings ResourcesNov. 12 Earnings ReportLatest Earnings DateNov. 12EstimatedConsensus EPS (Nov. 12) -$0.85 Actual EPS (Nov. 12) -$0.65 Beat By $0.20 Get Calidi Biotherapeutics Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Calidi Biotherapeutics and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataCLDI Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Calidi Biotherapeutics Analyst EPS EstimatesCurrent Year EPS Consensus Estimate ($4.48) EPSNext Year EPS Consensus Estimate ($0.88) EPS Calidi Biotherapeutics Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails11/12/2024--$0.85-$0.65+$0.20-$0.65--8/13/2024Q2 2024-$1.43-$1.40+$0.03-$1.40--5/14/2024Q1 2024-$2.70-$2.00+$0.70-$0.20--11/14/2023Q3 2023--$1.40--$0.14-- Calidi Biotherapeutics Earnings - Frequently Asked Questions When did Calidi Biotherapeutics announce their last quarterly earnings? Calidi Biotherapeutics (NYSE:CLDI) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on CLDI's earnings history. Did Calidi Biotherapeutics beat their earnings estimates last quarter? In the previous quarter, Calidi Biotherapeutics (NYSE:CLDI) reported ($0.65) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.85) by $0.20. Learn more on analysts' earnings estimate vs. CLDI's actual earnings. How much profit does Calidi Biotherapeutics generate each year? Calidi Biotherapeutics (NYSE:CLDI) has a recorded net income of -$29.22 million. CLDI has generated $0.00 earnings per share over the last four quarters. What is Calidi Biotherapeutics' EPS forecast for next year? Calidi Biotherapeutics' earnings are expected to grow from ($4.48) per share to ($0.88) per share in the next year. More Earnings Resources from MarketBeat Related Companies MGX Earnings Date EXOZ Earnings Date VXRT Earnings Date EPIX Earnings Date ANRO Earnings Date BYSI Earnings Date ELUT Earnings Date SRZN Earnings Date IPA Earnings Date CABA Earnings Date Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon's Earnings: What Comes Next and How to Play ItApple Stock: Big Earnings, Small Move—Time to Buy?Microsoft Blasts Past Earnings—What’s Next for MSFT?Visa Beats Q3 Earnings Expectations, So Why Did the Market Panic?Spotify's Q2 Earnings Plunge: An Opportunity or Ominous Signal?RCL Stock Sinks After Earnings—Is a Buying Opportunity Ahead?Amazon's Pre-Earnings Setup Is Almost Too Clean—Red Flag? This page (NYSE:CLDI) was last updated on 8/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Calidi Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Calidi Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CLDI Stock Alerts